osw 1 has been researched along with vidarabine in 1 studies
Studies (osw 1) | Trials (osw 1) | Recent Studies (post-2010) (osw 1) | Studies (vidarabine) | Trials (vidarabine) | Recent Studies (post-2010) (vidarabine) |
---|---|---|---|---|---|
57 | 0 | 31 | 4,976 | 974 | 1,525 |
Protein | Taxonomy | osw 1 (IC50) | vidarabine (IC50) |
---|---|---|---|
Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.062 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carney, DA; Estrov, Z; Garcia-Prieto, C; Harris, DM; Huang, P; Jin, Z; Kang, Y; Keating, MJ; Kondo, S; Liu, J; Lou, C; Pelicano, H; Xu, RH; Yu, W; Zhou, Y | 1 |
1 other study(ies) available for osw 1 and vidarabine
Article | Year |
---|---|
OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action.
Topics: Antineoplastic Agents; Apoptosis; Calcium Channels; Cell Line, Tumor; Cholestenones; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopy, Electron; Mitochondrial Membranes; Saponins; Vidarabine | 2005 |